Valirx (VAL)

 

Latest News

Quarterly Update on Clinical Developments

RNS Number: 6226J ValiRx PLC 13 September 2016 Va li R x P lc ("ValiRx" or "the Company") QUARTERLY UPDATEON CLINICAL DEVELOPMENTS London, UK ., 13 September 2016: ValiRx Plc (AIM: VAL), a life science company, which focuses on clinical stage cancer therapeutic development, taking proprietary & novel technology for precision medicines...

ValiRx - Quarterly update on clinical developments

Valirx Plc to present at the SHARES Investor Evening in Edinburgh on 5th October 2016

Dr. George Morris, Chief Operations Officer of Valirx (VAL) (LSE:VAL) will be giving a briefing at the SHARES Investo...

Placing, issue of warrants & Convertible Loan

RNS Number: 8528I ValiRx PLC 02 September 2016 Va li R x P lc ("ValiRx" or "the Company" or "the Group") Placing, issue of warrants and Convertible Loan Facility London, UK ., 02 September 2016: ValiRx Plc (AIM: VAL), a life science company, which focuses on clinical stage cancer therapeutic development, taking proprietary & novel technology for precision...

All News

DateHeadlineSource
13-09-16Quarterly Update on Clinical DevelopmentsRNS
13-09-16ValiRx - Quarterly update on clinical developmentsBRR Media
09-09-16Valirx Plc to present at the SHARES Investor Evening in Edinburgh on 5th October 2016StockMarketWire
02-09-16Placing, issue of warrants & Convertible LoanRNS
19-08-16Valirx Plc to present at the Shares LIVE Show in London on 10th September 2016StockMarketWire
11-08-16ValiRx gives ValiSeek clinical development updateStockMarketWire
11-08-16ValiSeek Clinical Development UpdateRNS
11-08-16ValiRx Plc - ValiSeek clinical development updateBRR Media
04-08-16Issue of EquityRNS
29-07-16ValiRx - New Zealand Patent Grant AllowanceBRR Media
28-07-16ValiRx notes notification of NZ Patent Grant AllowanceStockMarketWire
28-07-16Notification of New Zealand Patent Grant AllowanceRNS
26-07-16ValiRx issues equity, discontinues Bracknor facilityStockMarketWire
26-07-16Issue of Equity and Bracknor Facility UpdateRNS
14-07-16ValiRx issues ValiSeek clinical development update StockMarketWire
14-07-16ValiSeek Clinical Development UpdateRNS
14-07-16ValiRx - ValiSeek Clinical Development UpdateBRR Media
12-07-16Result of GMRNS
07-07-16Sale of TRAC Technology Rights for EUR 0.8 millionRNS
27-06-16Notice of GMRNS
20-06-16Result of AGMRNS
08-06-16Valirx - Quarterly update on clinical developmentsBRR Media
07-06-16Quarterly UpdateRNS
07-06-16Appointment of Joint BrokerRNS
26-05-16Posting of Annual Report & Notice of AGMRNS
20-05-16Valirx - Final Results 2015BRR Media
19-05-16Final ResultsRNS
19-05-16ValiRx issues ValiSeek clinical development update StockMarketWire
19-05-16ValiSeek Clinical Development UpdateRNS
18-05-16Conversion of Loan Note, issue of warrant & equityRNS
03-05-16Valirx Plc to present at the SHARES Investor Evening in London on 19th MayStockMarketWire
29-04-16ValiRx get notice of US Patent Grant for VAL401 StockMarketWire
29-04-16Notification of US Patent Grant for VAL401RNS
29-04-16Valirx - Notification of US Patent Grant for VAL401BRR Media
26-04-16ValiRx issues sharesStockMarketWire
26-04-16Issue of EquityRNS
22-04-16ValiRx to exhibit at the UK Investor ShowRNS
19-04-16ValiRx loan note conversion StockMarketWire
19-04-16Issue of Equity - conversion of loan noteRNS
18-04-16Issue of Equity - conversion of loan noteRNS

RSS feeds

  • Editorial news feed for LSE:VAL Editorial
  • Regulatory news feed for LSE:VAL Regulatory